|
Primary outcome
|
|
Cotinine level
| |
X
| | | |
X
|
|
Secondary outcomes
|
|
Nicotine dependence (Fagerström)
|
X
| | |
X
|
X
| |
|
MAP-HSS + smoking related complaints of smokers
|
X
| | |
X
|
X
|
X
|
|
Depression, anxiety and stress (DASS21)
|
X
| | |
X
|
X
|
X
|
|
Quality of Life (Euroqol 5D)
|
X
| | |
X
| | |
|
Smoking status
|
X
|
X
| |
X
|
X
|
X
|
|
Adherence
| | | | | |
X
|
|
Costs
| | | | | |
X
|
|
Baseline predictors and moderators of treatment effect
|
|
Internet Skills
|
X
| | | | | |
|
Readiness to change
|
X
| | | | | |
|
Attitude
|
X
| | |
X
|
X
| |
|
Social Influence
|
X
| | | | | |
|
Self-Efficacy
|
X
| | |
X
| | |
|
Alcohol/substance (mis)use
|
X
| | |
X
| | |
|
Descriptive variables
|
|
Patient characteristics and medical history
|
X
| | | | | |
|
Smoking history
|
X
| | | | | |
|
Stop Smoking History
|
X
| | | | | |
|
Other information of interest
|
|
Evaluation of treatment
| |
X
| |
X
|
X
|
X
|
|
Exhaled carbon monoxide (CO) level
|
X
|
X
|
X
| | |
X
|
